Zobrazeno 1 - 10
of 16
pro vyhledávání: '"33"'
Autor:
Varun Dhir, Shefali Khanna Sharma, Jasmina Ahluwalia, Ashwani Sood, Atit A Gawalkar, Aman Sharma, Ajay Bahl
Publikováno v:
Lupus. 29:1503-1508
Background Small case-series have reported overt myocardial dysfunction to be associated with positive antiphospholipid antibodies in patients of systemic lupus erythematosus (SLE). However, there is no case-control study that has examined this assoc
Autor:
Fulvia Ceccarelli, Guido Valesini, Francesca Romana Spinelli, Cristiana Barbati, Cristiano Alessandri, L. Novelli, Carlo Perricone, Fabrizio Conti, Roberto Perricone
Publikováno v:
Lupus. 28:621-628
BackgroundAdhesion molecule CD44 contributes to T cell migration into target organs. A higher expression of CD44v3 and v6 isoforms has been identified on T cells from systemic lupus erythematosus (SLE) patients. The aim of this study was to investiga
Publikováno v:
Lupus. 28(3)
Objective We analyzed data of lupus nephritis (LN) patients to find parameters that can predict remission. Methods Sixty-four LN patients who were diagnosed with class III, IV, V or V + III/IV by renal biopsy and were followed up for more than six mo
Publikováno v:
Lupus. 19:300-306
Neonatal lupus is a model of passively acquired autoimmunity whereby anti-SSA/Ro-SSB/La antibodies target the fetal heart and neonatal skin in a minority of cases. Since neuro-psychiatric impairment has been reported in humans and mice exposed prenat
Publikováno v:
Lupus. 18:713-717
The aim of this article is to compare the prevalence of anti-cyclic citrullinated peptide (anti-CCP) antibodies in systemic lupus erythematosus (SLE) patients with and without arthritis and in patients with rheumatoid arthritis (RA). Anti-CCP antibod
Publikováno v:
Lupus. 14:129-136
The antiphospholipid syndrome (APS) is characterized by the presence of antiphospholipid antibodies (aPL) in patients with thromboembolic complications. In APS, most aPL are autoantibodies to β2-glycoprotein I and prothrombin, which play a major rol
Publikováno v:
Lupus. 13:36-44
The objective of this paper is to investigate the association between patterns of anti-dsDNA antibody isotypes and specific clinical manifestations (categorized in renal, musculoskeletal, cutaneous, hematological, pulmonary, neurologicaland cardiac).
Publikováno v:
Lupus. 12:112-116
Thrombotic complications are a significant cause of morbidity and mortality in cancer patients. Studies in Caucasian populations have shown that up to one-third of such patients test positive to antiphospholipid antibodies. Our aim was to determine t
Autor:
G Tsariktsian, Ricardo Forastiero, L O Carreras, M M Sturno, B. Alonso, M. E. Martinuzzo, G F de Larrañaga
Publikováno v:
Lupus. 9:594-600
Antiphospholipid antibodies (aPL) have been reported not only in autoimmune disorders but also in various infectious diseases. Accumulating evidence indicates that b2glycoprotein I (b2GPI) and prothrombin are the main proteins to which autoimmune aPL
Publikováno v:
Lupus. 7:347-354
We measured the serum levels of soluble vascular cell adhesion molecule-1 (sVCAM-1), soluble E-selectin (sE-selectin) and soluble intercellular adhesion molecule-1 (sICAM-1) in 72 patients with systemic lupus erythematosus (SLE) (including patients w